春立医疗中期报告2023

（於中華人民共和國註冊成立的股份有限公司） 股份代號:1858 2023中期報告 2 3 16 19 20 22 24 26 27 29 31 33 35 20236 2820236 28 10 20820 http://www.clzd.com 2023 12 202292023 20236 30102PRP34III21II47I 2023 20G20 20236 30 ••2020•2022••III•• •••VE•••INS-1 20236 30 •2021•2022•20222022XJR0038•20222022ZJTX0032•2021GR202111003321•202320232090332204•2022•2022•2022 20233CNAS E20223130744202231308683D3D 20236 30 PEEK 3D PRP 19CECE 20236 305289342348 20154BIOLOX®deltaBIOLOX®deltaCeramTec20205BIOLOX®OPTIONBIOLOX®OPTIONBIOLOX®deltaTi6Al4V •160XCP2020SY0402•XCP2021SY0388•XCP2021SY0385•XCP2021SY0384•XCP2020SY0404•XCP2021SY0386•XCP2020SY0403•CFXCP2021SY0382•XCP2021SY0383•XCP2021SY0387 OEM 20236 30540.71571.395.37% 2023630391.41425.808.08% 20236 3072.39%74.52%2.13%12 2023630166.89155.017.66% 202363018.9615.4622.64% 202363074.5772.293.15%202313.79% 20236 308.7914.3138.57% 202363012.5515.4118.56% 2023630125.99156.9819.74% 202212 31957.1920236 30855.12 AH H20153 11185.8620152 27 (2021) 3702202112 30AA3,842.8029.81A1,145,538,680.0078,410,387.77A1,067,128,292.23A202112 14A20221 18 A 202212 31259.7920236 30387.39 202212 31463.401.82%20236 30471.84 202212 312,183.2820236 302,171.08 20236 3038.9763.930.1320222023102.37 20236 30 32(4A)20236 305% 1601169 220051093920079601939 A PRP 3D PRP 20236 301,37920236 30135.89 20236 306 20236 30 20236 30 20236 30 20236 30XVXV78352 20236 30XV352 20236 30XV23336 1.20236 30288,428,000A95,140,500H 2.20236 30383,568,500 20236 30XV23336 115100083WUYIGE Certified Public Accountants.LLP15/F, Xueyuan International TowerNo. 1 Zhichun Road, Haidian Dist.Beijing, China, 100083Telephone+86(10) 82330558Fax+86(10) 82327668Internetwww.daxincpa.com.cn 20236 3020231-6 2101 20236 3020231-6 • 20231-6 20231-6 1.2. 20231-6 113,727,109.44155,168,038.58 20231-6 20231-6 20231-6 20231-6 20231-6 20231-6 20231-6 20231-6 19982 1291110000633737758W38,428.0038,356.85120153 1101858.HK2021 12 30688236.SH -6846-1-6846-2 20238 30 12 20236 3020231-6 111231 12 1. 2. 1. 2. 3. 4. 5. 1. (1) 1. (1) (2) 2. 2. (1) (2) 3. 4. (1) (2) 1. (1)12(2)(3) (1) 1. (2) 14 1 2 32 1 2 21 1. (3) (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14) 1 2 3 2. 2. (1)(2)(3) 4. 5. 1. 2. 1. 127 2. 22 20%50%20% 1. 2. 1. 2. 3 1. 2. 3.(1)(2)(3)(4)(5) 1. 2. 3. 4. 1)2)3)4)5)6) 1. 3. 1. 2. 1. 2. 1. 2. 3. 1. (1) 8 (2) 2. (2) 20231 116 20211217GR20211100332120212022202315% 20219 18GR20211300123720212022202315% 2023610025%20% 233,101,255.1925,165,496.137,935,759.06 1. 2. 3. 1. (5) 1. 2. (1) 1.2.3.4. 2147,934,037.09 (2)20236 30 (1) 1.2.3.4. 1.2.3.4. 12.50% 20236 30 1. 1. 1. 1. 2. 1. 70%11,000,000.0012,050,0006,500,000.006,500,0002,65070% 2. 1. 2. 1. 2. 20236 30202212 31 745,055,516.20690,066,911.193,472,457,994.373,409,766,690.9121.46%20.24% = 1. 20236 30 1. 2. 1 1,249,719.73 1. 2.(1)1 (5) 1. 2. 35112